TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10407200

Group type: EXPERIMENTAL
Intervention: Spatial condition of a delayed-response task
Number of subjects: 6

Group type: COMPARATOR
Intervention: Nonspatial task with same response contingencies
Number of subjects: 6
Study: 7560698

Group type: EXPERIMENTAL
Intervention: First physical activity program (sit-to-stand repetitions, transferring, walking, wheelchair propulsion) performed every 2 hours during the daytime, 5 days per week for 9 weeks
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Second physical activity program (rowing in wheelchair-accessible rowing machine, walking, wheelchair propulsion) performed once per day, three times per week for 9 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 65
Study: 2285640

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 7307591

Group type: EXPERIMENTAL
Intervention: Indomethacin therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no indomethacin therapy)
Number of subjects: 11
Study: 30651130

Group type: EXPERIMENTAL
Intervention: Trans-tympanic injection of sodium thiosulfate gel in the left or right ear
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control ears (no treatment)
Number of subjects: 13
Study: 28340430

Group type: EXPERIMENTAL
Intervention: Bilateral sequential stimulation (BSS) with theta burst stimulation (TBS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ipsilateral facilitatory (intermittent TBS [iTBS] over non-dominant M1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Contralateral inhibitory (continuous TBS [cTBS] over dominant M1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 40
Study: 26343013

Group type: EXPERIMENTAL
Intervention: G10 (10% crude glycerine)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: G5 (5% crude glycerine)
Number of subjects: 90

Group type: COMPARATOR
Intervention: G0 (control, conventional feed)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Castrated males
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: G10
Number of subjects: 90
Study: 24856433

Group type: EXPERIMENTAL
Intervention: Early oral feeding (after 2 hours)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Conventional oral feeding (after 18 hours)
Number of subjects: 1174
Study: 22612913

Group type: EXPERIMENTAL
Intervention: Lumbar fusion (N = 60)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cognitive therapy and exercises (N = 33)
Number of subjects: 93
Study: 19528286

Group type: EXPERIMENTAL
Intervention: 800 mg PA-824
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 1,000 mg PA-824
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 18086974

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy
Number of subjects: 130
Study: 14674937

Group type: EXPERIMENTAL
Intervention: Allergen specific immunotherapy (SIT) with standardized birch pollen extract
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 12058842

Group type: EXPERIMENTAL
Intervention: Imitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Contingently responsive
Number of subjects: 20
Study: 9810420

Group type: EXPERIMENTAL
Intervention: Hypotrophic newborns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mothers of hypotrophic newborns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mothers and newborns in both groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cord serum alpha-2-M concentrations
Number of subjects: 0
Study: 7646570

Group type: EXPERIMENTAL
Intervention: Quinidine sulphate 250 mg administered at 10:00 h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinidine sulphate 250 mg administered at 22:00 h
Number of subjects: 0
Study: 31495672

Group type: EXPERIMENTAL
Intervention: Early Intervention (EI) - Computer-Based Cognitive Rehabilitation (CBCR) training immediately after inclusion for 3 weeks (m = 19 days after stroke onset)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Late Intervention (LI) - Computer-Based Cognitive Rehabilitation (CBCR) training after a 3-week wait for 3 weeks (m = 44 days after stroke onset)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (LI)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups (EI and LI)
Number of subjects: 14
Study: 28514527

Group type: EXPERIMENTAL
Intervention: Robenacoxib (2.0 mg/kg SC injection prior to surgery and for 2 additional days postoperatively)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo (SC injection prior to surgery and for 2 additional days postoperatively)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Robenacoxib
Number of subjects: 317
Study: 26001091

Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (with exopolysaccharides)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (without exopolysaccharides)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Yoghurt
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference meal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (with and without exopolysaccharides)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Presence of microbial exopolysaccharides
Number of subjects: 18
Study: 23811267

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left DLPFC
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 11
Study: 19823807

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (Neurobloc)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18210765

Group type: EXPERIMENTAL
Intervention: Diet plus rosiglitazone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Diet plus metformin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 41
Study: 15811762

Group type: EXPERIMENTAL
Intervention: Stylet group (n = 109)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (n = 107)
Number of subjects: 216
Study: 12037435

Group type: EXPERIMENTAL
Intervention: Low-dose botulinum toxin (BTX) treatment (mean total target dose of 547 +/- 113 mouse units)
Number of subjects: 31

Group type: COMPARATOR
Intervention: 4-times-diluted preparation (130 +/- 32 MU)
Number of subjects: 31
Study: 9988391

Group type: EXPERIMENTAL
Intervention: In vitro culture of dissected testicular biopsy samples at 37 degrees C for up to 96 hours.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Incubation of immotile testicular spermatozoa in pentoxifylline and 2‐deoxyadenosine for 30 minutes.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Culture of tissue blocks.
Number of subjects: 10
Study: 7486097

Group type: EXPERIMENTAL
Intervention: Epidural clonidine (4 micrograms/kg in 10 mL) infused in 20 min followed by a 2-micrograms.kg-1.h-1 infusion (5 mL/h) during 12 h (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sufentanil (0.5 microgram/kg in 10 mL) in 20 min followed by a 0.25-microgram.kg-1.h-1 infusion (5 mL/h) during 12 h (Group 2)
Number of subjects: 40
Study: 2137971

Group type: EXPERIMENTAL
Intervention: Nafarelin, 400 and 800 micrograms administered intranasally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Danazol, 600 and 800 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 0
Study: 6770408

Group type: EXPERIMENTAL
Intervention: Alcohol 0.45 ml/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alcohol 0.90 ml/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sleep deprivation (26 h)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined alcohol (0.45 ml/kg and 0.90 ml/kg) and sleep deprivation (26 h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (0 ml/kg alcohol and no sleep deprivation)
Number of subjects: 24
Study: 30370852

Group type: EXPERIMENTAL
Intervention: Fomentex herbal tea 11.2 g/day in 2 divided doses for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medroxy progesterone acetate (MP) 10 mg/day for the last 10 days of their menstrual cycles
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fomentex herbal tea
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medroxy progesterone acetate (MP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 30545748

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (approximately 2 standard drinks)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo drink (nonalcoholic)
Number of subjects: 23
Study: 28962586

Group type: EXPERIMENTAL
Intervention: Treatment intensification (methotrexate + tapered high-dose prednisone)
Number of subjects: 610
Study: 26189118

Group type: EXPERIMENTAL
Intervention: Iterative image reconstruction (IR) with 30% tube current reduction
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard filtered back projection (FBP) image reconstruction with standard tube current
Number of subjects: 400
Study: 23665027

Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg QD
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 20646706

Group type: EXPERIMENTAL
Intervention: Breast health promotion program (120-min duration including education, film, instruction, booklet, calendar, card)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Breast health promotion program
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (general information except breast health)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190
Study: 19250050

Group type: EXPERIMENTAL
Intervention: Ga‐As laser therapy combined with a 12‐wk comprehensive home exercise program
Number of subjects: 44

Group type: COMPARATOR
Intervention: 12‐wk comprehensive home exercise program alone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 17374703

Group type: EXPERIMENTAL
Intervention: Diabetic patients with increased IMT (mean IMT 1.6 +/- 0.6)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Healthy controls (mean IMT 0.3 +/- 0.1)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Diabetic patients with hypertension (mean IMT 0.475 +/- 0.03 mm)
Number of subjects: 208
Study: 15719220

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12486586

Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 4630

Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring at stage C
Number of subjects: 4630

Group type: COMPARATOR
Intervention: Narcotrend monitoring at stage F
Number of subjects: 4630
Study: 9814462

Group type: EXPERIMENTAL
Intervention: T4 (levothyroxine) treatment (21 patients, 2.7 +/- 0.3 microg/kg, TSH < 0.3 microIU/mL)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (24 patients)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: T4 (levothyroxine) treatment
Number of subjects: 45
Study: 7665802

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (patients without depression)
Number of subjects: 50
Study: 2473363

Group type: EXPERIMENTAL
Intervention: Combined chemo‐radiotherapy [2 X (COPP + ABVD) + 40 Gy extended field irradiation (EF)]
Number of subjects: 226

Group type: COMPARATOR
Intervention: Combined chemo‐radiotherapy [2 X (COPP + ABVD) + 20 Gy EF]
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy [3 X (COPP + ABVD)]
Number of subjects: 226

Group type: COMPARATOR
Intervention: Chemotherapy [1 X (COPP + ABVD)]
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Salvage therapy (radiotherapy in case of persisting nodal disease; chemotherapy with 4 X CEVD in case of persisting disseminated disease)
Number of subjects: 226
Study: 132915

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 6
Study: 31943055

Group type: EXPERIMENTAL
Intervention: Intensive intervention (interpersonal counseling, community mobilization, mass media campaigns)
Number of subjects: 8565

Group type: EXPERIMENTAL
Intervention: Intensive intervention
Number of subjects: 8565

Group type: COMPARATOR
Intervention: Nonintensive intervention
Number of subjects: 8565
Study: 29845833

Group type: EXPERIMENTAL
Intervention: PNF stretching combined with electrostimulation (TENS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: PNF stretching with voluntary contraction (Control)
Number of subjects: 30
Study: 28584913

Group type: EXPERIMENTAL
Intervention: Triazolam 0.0625 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triazolam 0.250 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (T0)
Number of subjects: 24
Study: 26895618

Group type: EXPERIMENTAL
Intervention: 35-mm follicles
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 40-mm follicles
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Impending ovulation follicles
Number of subjects: 30

Group type: COMPARATOR
Intervention: 40-mm and impending ovulation follicles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Impending ovulation group
Number of subjects: 30
Study: 24899762

Group type: EXPERIMENTAL
Intervention: Active CPAP (n = 34)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham CPAP (n = 31)
Number of subjects: 65
Study: 22218384

Group type: EXPERIMENTAL
Intervention: Humeral head resurfacing
Number of subjects: 7

Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 7
Study: 19285307

Group type: COMPARATOR
Intervention: Standard antiseptic measures
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Extensive antiseptic measures
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Lapses in discipline
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Intestinal anastomosis
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Duration of operation more than 3 hours
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Body mass index >30 kg/m2
Number of subjects: 1032
Study: 17461726

Group type: EXPERIMENTAL
Intervention: (32)P‐chromic phosphate colloids (32)P‐CP) administered via multipointed infiltrative injection
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (simple operative group without (32)P‐CP injection)
Number of subjects: 190
Study: 16602632

Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment for two months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normocholesterolemic controls
Number of subjects: 0
Study: 12414556

Group type: EXPERIMENTAL
Intervention: High anxiety as a stable trait and personality traits such as high novelty seeking and low harm avoidance.
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Scale and STAI-X2 for anxiety measurement.
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Tridimensional Personality Questionnaire.
Number of subjects: 521
Study: 10456462

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (coronary angioplasty alone)
Number of subjects: 55
Study: 7604799

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg once daily for 4 weeks, then 40 mg twice daily for 12 weeks
Number of subjects: 134

Group type: COMPARATOR
Intervention: Pravastatin 20 mg once daily for 4 weeks, then 40 mg once daily for 12 weeks
Number of subjects: 134
Study: 2227077

Group type: EXPERIMENTAL
Intervention: 10 mg ketorolac given orally every 6 h for up to 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: 50 mg pentazocine given orally every 6 h for up to 7 days
Number of subjects: 40
Study: 452941

Group type: EXPERIMENTAL
Intervention: Mefruside (25 mg daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Atenolol (100–400 mg daily)
Number of subjects: 42
Study: 31908162

Group type: EXPERIMENTAL
Intervention: Ischaemic heart disease (IHD)
Number of subjects: 30946

Group type: COMPARATOR
Intervention: Non-ischaemic heart disease (non-IHD)
Number of subjects: 30946
Study: 31945586

Group type: EXPERIMENTAL
Intervention: Iloprost infusion (1 ng/kg/min)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 46
Study: 30114658

Group type: EXPERIMENTAL
Intervention: oxaliplatin-fluoropyrimidine chemotherapy with cetuximab
Number of subjects: 2183

Group type: COMPARATOR
Intervention: oxaliplatin-fluoropyrimidine chemotherapy
Number of subjects: 2183
Study: 27734441

Group type: EXPERIMENTAL
Intervention: Combat Ready Clamp (CRoC)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: SAM® Junctional Tourniquet (SJT)
Number of subjects: 84
Study: 24762768

Group type: EXPERIMENTAL
Intervention: Gelclair® mouthwash used 3 times a day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 57
Study: 23018166

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo Reiki
Number of subjects: 30
Study: 20226404

Group type: EXPERIMENTAL
Intervention: Laparoscopic cystectomy with the vasopressin injection technique
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ordinary laparoscopic cystectomy without injection
Number of subjects: 15

Group type: COMPARATOR
Intervention: Laparoscopic cystectomy with the injection of saline solution
Number of subjects: 15
Study: 19112723

Group type: EXPERIMENTAL
Intervention: Metoprolol (starting dose 50 mg bid)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Clonazepam (starting dose 0.5 mg qd)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 54

Group type: COMPARATOR
Intervention: Clonazepam
Number of subjects: 54
Study: 16181303

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg (once per day)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 12719203

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: Aspirin (low-risk patients)
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: Aspirin (validation set low-risk patients)
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: Therapeutic oral anticoagulation therapy (low-risk patients)
Number of subjects: 2501
Study: 10233567

Group type: EXPERIMENTAL
Intervention: Suprapubic drainage via the Freka(R) CystTUR Standard device
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Iglesias continuous‐flow resectoscope
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Suprapubic drainage using the Korth 'flow controller'
Number of subjects: 90
Study: 8723141

Group type: EXPERIMENTAL
Intervention: FCE 23,884 monotherapy (3.5 +/- 0.5 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: FCE 23,884 coadministered with a mildly dyskinetic dose of levodopa
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1885444

Group type: EXPERIMENTAL
Intervention: Progressive hypercapnia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Inspiratory threshold loading (‐40 cmH2O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combined hypercapnia and loading
Number of subjects: 7
Study: 6685515

Group type: EXPERIMENTAL
Intervention: oxazepam (Sigacalm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: standard oxazepam formulation
Number of subjects: 14
Study: 30025745

Group type: EXPERIMENTAL
Intervention: Trimodal prehabilitation (exercise, nutrition, anxiety-reduction) starting 4 weeks before surgery and continuing for 8 weeks after surgery.
Number of subjects: 139

Group type: COMPARATOR
Intervention: Trimodal rehabilitation (identical to prehabilitation but initiated only after surgery).
Number of subjects: 139
Study: 29344631

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT) - 12 sessions, 60 minutes each
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET) - 5 sessions, 60 minutes for the first session and 40 minutes for the remaining sessions
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126
Study: 27220694

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) for 12 weeks (1-week in-hospital training followed by 11-week outpatient program)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No intervention (non-CR group)
Number of subjects: 41
Study: 25063985

Group type: EXPERIMENTAL
Intervention: Prenatal meditation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (no prenatal meditation)
Number of subjects: 123
Study: 22431582

Group type: EXPERIMENTAL
Intervention: Diesel exhaust exposure (200 μg/m(3) of fine particulate matter) for 120 minutes
Number of subjects: 45

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 45
Study: 19190038

Group type: EXPERIMENTAL
Intervention: Retroperitoneal approach (Group I)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Transperitoneal approach (Group II)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Transperitoneal approach (Group III)
Number of subjects: 35
Study: 17997151

Group type: EXPERIMENTAL
Intervention: Single oral dose of 300 mg tenofovir disoproxil fumarate with 200 mg emtricitabine
Number of subjects: 400

Group type: COMPARATOR
Intervention: No study drug (control)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study: 15486039

Group type: EXPERIMENTAL
Intervention: Ketorolac (45 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 24
Study: 12214151

Group type: EXPERIMENTAL
Intervention: 10-20 mg quinapril for 6 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50-100 mg losartan for 6 months
Number of subjects: 60
Study: 9825750

Group type: EXPERIMENTAL
Intervention: Combined step-down prednisolone, methotrexate and sulphasalazine
Number of subjects: 154

Group type: COMPARATOR
Intervention: Sulphasalazine alone
Number of subjects: 154
Study: 7656941

Group type: EXPERIMENTAL
Intervention: Falls in Peak Expiratory Flow (PEF) episodes
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Upper and lower respiratory tract symptom events
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: PEF episodes preceded by respiratory symptoms
Number of subjects: 192